Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Scale Up Life Science Invest AB
AB
Active
Org 5594100439
Västra Järnvägsgatan 9 F, 753 33
Uppsala
Other activities auxiliary to financial services, except insurance and pension funding
· NACE 6619
Est. 2022
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other activities auxiliary to financial services, except insurance and pension funding
/
Scale Up Life Science Invest AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
145
72
Staff expenses
—
—
EBITDA
70
−92
Depreciation & amort.
—
—
EBIT
70
−92
Net financials
255
57
Profit before tax
325
−35
Tax
−76
—
Net profit
249
−35
Balance sheet
SEK thousands
Item
2023
2024
Total assets
18 365
17 305
Equity
17 254
17 219
Long-term debt
—
—
Short-term debt
1 111
86
Total debt
1 111
86
Financial ratios
5-year trend
EBITDA margin
-127.0%
This company
15.8%
Market median
-904% vs market
2023
2024
Equity ratio
99.5%
This company
38.2%
Market median
+160% vs market
2023
2024
Return on equity
-0.2%
This company
18.4%
Market median
-101% vs market
2023
2024
Net profit margin
-48.5%
This company
8.1%
Market median
-699% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-12-06 – 2023-12-31
View
PDF
More on Scale Up Life Science Invest AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
